(ACT) Enact Holdings - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29249E1091

ACT: Mortgage Insurance, Reinsurance, Underwriting Services

Enact Holdings, Inc. (NASDAQ:ACT), operating under the banner of private mortgage insurance, is a pivotal player in the U.S. residential mortgage sector. Their core business revolves around underwriting and assuming mortgage guaranty insurance, essentially mitigating the risk for lenders offering high loan-to-value mortgages. This role is crucial in expanding homeownership, though it comes with inherent risks tied to economic fluctuations and housing market dynamics.

The companys service portfolio extends beyond insurance, encompassing contract underwriting and mortgage-related reinsurance. These offerings not only diversify their revenue streams but also illustrate a strategic approach to risk management. By reinsuring portions of their insurance portfolio, Enact effectively balances its exposure, a prudent move in an industry sensitive to economic shifts.

Originally known as Genworth Mortgage Holdings, Enact rebranded in 2021, signaling a new chapter while retaining its foundational expertise. Founded in 1981 and headquartered in Raleigh, North Carolina, Enact functions as a subsidiary of Genworth Holdings, Inc., leveraging this relationship for operational and strategic support.

From a financial standpoint, Enacts market capitalization exceeds $5 billion, underscoring its significant presence in the industry. The P/E ratio of 7.67 reflects moderate growth expectations, typical of a sector often valued for stability over rapid expansion. The P/S ratio of 4.30 indicates a reasonable valuation relative to revenue, suggesting a balance between market value and revenue generation.

For investors and fund managers, Enact presents an opportunity in a niche market with clear risk and return dynamics. The companys operational resilience and strategic risk management practices position it as a stable investment in the mortgage insurance landscape, where economic trends and regulatory changes play pivotal roles.

Additional Sources for ACT Stock

ACT Stock Overview

Market Cap in USD 5,235m
Sector Financial Services
Industry Insurance - Specialty
GiC Sub-Industry Property & Casualty Insurance
IPO / Inception 2021-09-16

ACT Stock Ratings

Growth 5y 72.7%
Fundamental 72.3%
Dividend 32.9%
Rel. Strength -4.3
Analysts 3.6/5
Fair Price Momentum 36.97 USD
Fair Price DCF 104.41 USD

ACT Dividends

Dividend Yield 12m 2.18%
Yield on Cost 5y 4.42%
Annual Growth 5y -6.38%
Payout Consistency 89.9%

ACT Growth Ratios

Growth Correlation 3m 73.9%
Growth Correlation 12m 55.8%
Growth Correlation 5y 96.5%
CAGR 5y 22.92%
CAGR/Max DD 5y 1.13
Sharpe Ratio 12m 0.97
Alpha 8.82
Beta 0.591
Volatility 21.44%
Current Volume 222.3k
Average Volume 20d 193.3k
What is the price of ACT stocks?
As of April 01, 2025, the stock is trading at USD 34.75 with a total of 222,328 shares traded.
Over the past week, the price has changed by +0.81%, over one month by +1.08%, over three months by +7.92% and over the past year by +15.56%.
Is Enact Holdings a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Enact Holdings (NASDAQ:ACT) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 72.25 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACT as of April 2025 is 36.97. This means that ACT is currently overvalued and has a potential downside of 6.39%.
Is ACT a buy, sell or hold?
Enact Holdings has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold ACT.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0
What are the forecast for ACT stock price target?
According to ValueRays Forecast Model, ACT Enact Holdings will be worth about 40.3 in April 2026. The stock is currently trading at 34.75. This means that the stock has a potential upside of +16.06%.
Issuer Forecast Upside
Wallstreet Target Price 38.6 11.1%
Analysts Target Price 38.6 11.1%
ValueRay Target Price 40.3 16.1%